参考文献/References:
[1] Webber L, Davies M, Anderson R,et al. ESHRE guideline: management of women with premature ovarian insufficiency [J]. Hum Reprod, 2016,31(2):926-937.
[2] Alvaro M B,Imbert R,Demeestere I,et al.AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency [J]. Hum Reprod, 2015,30(5):1196-1202.
[3] Gordon CM,Kanaoka T,Nelson LM. European society for human reproduction and embryology(ESHRE) guideline group on POI [J]. Curr Opin Pediatr,2015,27(4):511-519.
[4] Bricaire L, Laroche E, Bourcigaux N, et al. Premature ovarian failures [J].Presse Med,2013,42(11):1500-1507.
[5] Sills ES, Alper MM,Walsh AP. Ovarian reserve screening in infertility: practical applications and theoretical directions for research [J]. Eur J Obstet Gynecol Reprod Biol, 2009,146(1):30-36.
[6] Committee on Gynecologic Practice. Committee opinion No. 698:hormone therapy in primary ovarian insufficiency [J]. Obstet Gynecol, 2017,129(1):134-141.
[7] Aleksandra Kruszyńska. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause [J]. Menopause Rev ,2017,16(2): 47-50.
[8] Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women [J]. Hum Reprod Update, 2014,20(3):370-373.
[9] Oktay K,Rodriguez-Wallberg K,Munster P. Ovarian protection during adjuvant chemotherapy [J]. N Engl J Med,2015, 372(23):2268-2269.
[10] Aikawa NE, Sallum AM, Pereira RM,et al. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy [J].Clin Exp Rheumatol,2012,30(3):445-449.
[11] Ostensen M, Brucato A, Carp H,et al. Pregnancy and reproduction in autoimmune rheumatic diseases [J]. Rheumatology (Oxford), 2011,50(4):657-664.
[12] Michalakis K, Coppack SW. Primary ovarian insufficiency: relation to changes in body composition and adiposity [J]. Maturitas ,2012,71(2):320-325.
[13] De Vos M,Devroey P,Fauser BC. Primary ovarian insufficiency [J]. Lancet,2010,376(9744):911-921.
[14] Ott J,Pecnik P,Promberger R,et al. Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto’s thyroiditis [J].Climac Teric, 2014,17(1):92-96.
[15] Blumenfeld Z,Halachmi S,Peretz BA,et al. Premature ovarian failure.The prognostic application of autoimmunity on conception after ovulation induction [J]. Fertil Steril, 1993,59(1): 750-755.
[16] Baber RJ,Panay N,Fenton A,et al.2016 IMS Recommendations on women’s midlife health and menopause hormone therapy [J].Climacteric,2016,19(1):109-150.
[17] 齐 璐.更年期妇女保健中性激素替代疗法和常规保健治疗的价值对比分析 [J].养生保健指南,2018,17(22):372.
[18] 吴丽婷, 石 玥, 刘雁峰,等. 肖承悰治疗卵巢早衰经验 [J]. 中医杂志, 2017, 58(2):108-110.
[19] 秦佳佳,吴 倩,杨 静,等.卵巢早衰的病因病机及中医药干预策略 [J].中国老年学杂志，2014,23 (16) : 4720-4721.
[20] 康建颖,陆月红.中医辨证分型治疗对卵巢早衰患者卵巢功能恢复的影响 [J]. 中国妇幼保健, 2017, 32(16):3723-3725.
[21] 国家药典委员会. 中华人民共和国药典[M]. 北京:中国医药科技出版社,2010:306-307.
[22] 王焕珍,柴艺汇,陈云志,等.淫羊藿化学成分与药理作用研究进展 [J].亚太传统医药,2016,12(7):63-65.
[23] Xue L ,Jiang Y, Han T,et al. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim [J]. J Ethnopharmacol, 2016,36 (192):370-381.
[24] Ming L, Chen K, Xian CJ. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling [J]. J Cell Physiol, 2013,228(3):513-521.
[25] Yan QL,Xiao FH,Tiegang Liu,et al. A cell-based model of bone remodeling for identifying activity of icarrin in the treatment of osteoporosis. Biotechnol [J].Lett,2015,37(1):219-226.
[26] 杨裕华, 李 霞. 补肾中药对肾阳虚动物模型神经内分泌免疫系统影响的实验研究进展 [J]. 天津中医药,2007,24(3):262-263.
[27] Kang YK，Lee SB，Hyosuk K，et al． Peripubertal administration of icariin and icaritin advances pubertal development in female rats [J].Biomol Ther,2012,20 (2) :189-195.
[28] An R, Li B, You L,et al. Improvement of kidney yang syndrome by icariin through regulating hypothalamus-pituitary-adrenal axis [J]. Chin J Integr Med, 2015,21(10):1-7.
[29] Liang SR, Bi JW, Guo ZL,et al. Protective effect of icariin on kidney in 5/6 nephrectomized rats and its mechanism [J].Genet Mol Res,2013,13: 6466-6471.
[30] 杨利娟. 何首乌、骨碎补和淫羊藿抗骨质疏松的作用机理研究[D].成都: 成都中医药大学，2012.
[31] Yang L, Lu D, Guo J,et al. Icariin from Epimedium brevicornum maxim promotes the biosynthesis of estrogen by aromatase(CYP19) [J]. J Ethnopharmacol,2013,145(4): 715-721.
[32] 徐亚萍,陈佳慧,刘萌萌,等.淫羊藿苷对小鼠卵泡卵母细胞体外发育与成熟的影响 [J].畜牧与兽医, 2016, 48(5):105-107.
[33] Kang HK, Lee SB , Kwon H, et al. Peripubertal administration of icariin and icaritin advances pubertal development in female rats [J]. Biomol, 2012,20(2):189-195.
[34] 李芳芳,李 恩,吕占军,等.淫羊藿甙对大鼠卵泡颗粒细胞和肾上腺皮质细胞分泌功能的影响 [J].中国中药杂志,1997,22 (8) : 499-500.
[35] 叶海涌,刘 健,楼宜嘉.淫羊藿苷衍生物的制备及其雌激素样作用研究 [J].浙江大学学报:医学版,2005,34(2):40-45.
[36] 刘忠平,李质馨,李守远,等.淫羊藿对生殖系统影响 [J].中国妇幼保健,2013,28 (5):884-886.
[37] Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment [J]. Obstet Gynecol Clin North Am, 2015,42(1): 153-161.
相似文献/References:
[1]杨亮,李富贤.《伤寒论》与《金匮要略》中现版药典未收录药名考证[J].陕西中医,2016,(10):1421.
[2]孙明明,李 聪,史 林.王庆国教授对慢性萎缩性胃炎的治疗经验探析[J].陕西中医,2019,(2):260.
SUN Mingming,LI Cong,SHI Lin..Analysis on the treatment experience of chronic atrophic gastritis by professor WANG Qingguo[J].,2019,(5):260.
[3]张 艳,贾淑亚.不同时间温针灸配合中药治疗寒湿凝滞型痛经临床研究*[J].陕西中医,2019,(1):122.
ZHANG Yan,JIA Shuya..Clinical study on treating cold and damptype dysmenorrhea with warm acupuncture and Chinese herbs at different time[J].,2019,(5):122.
[4]于晨媛.滋肾益坤清心汤联合地屈孕酮对卵巢早衰患者性激素水平及免疫指标的影响[J].陕西中医,2019,(6):740.
YU Chenyuan..Effects of Zishen Yikun Qingxin decoction combined with progesterone on sex hormone levels and immune indexes in patients with premature ovarian failure[J].,2019,(5):740.
[5]刘颖洁,王小平,张 宇,等.消瘿方凝胶治疗消融术后甲状腺结节疗效研究*[J].陕西中医,2019,(9):1241.
[6]包君丽,韩宇博,刘 莉△.中医药治疗阻塞性睡眠呼吸暂停综合征用药规律*[J].陕西中医,2020,(3):398.
BAO Junli,HAN Yubo,LIU Li..Rule of traditional Chinese medicine in treatment of obstructive sleep apnea hypopnea syndrome[J].,2020,(5):398.
[7]陈佳妮,孙 琳,程亭亭,等.中药缓解5-氟尿嘧啶类化疗药物所致贫血Meta分析*[J].陕西中医,2020,(9):1324.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.042]
CHEN Jiani,SUN Lin,CHENG Tingting,et al.Meta analysis of traditional Chinese medicine in alleviating anemia caused by 5-fluorouracil-based chemotherapeutic drugs[J].,2020,(5):1324.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.042]
[8]高宁珂,王克华,闫 姝.免疫性卵巢早衰中西医诊疗进展[J].陕西中医,2021,(10):1480.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.041]
[9]李格铬,崔晓萍,宜 莉,等.卵巢早衰的中医研究进展[J].陕西中医,2023,(4):534.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.029]
LI Gege,CUI Xiaoping,YI Li,et al.Research progress of Chinese medicine in premature ovarian failure[J].,2023,(5):534.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.029]
[10]王巢屹,周建惠,王 秋,等.名中医姜丽娟从“阴阳失衡”角度论治卵巢早衰常用对药撷萃[J].陕西中医,2025,46(5):685.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.024]
WANG Chaoyi,ZHOU Jianhui,WANG Qiu,et al.Professor JIANG Lijuan discusses the extraction of commonly used drugs for treating premature ovarian failure from the perspective of yin-yang imbalance[J].,2025,46(5):685.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.024]
[11]钟钰,卜亚丽,王亦姝,等.名中医李坤寅基于“精不足者，补之以味”及五脏苦欲补泻理论论治卵巢早衰经验[J].陕西中医,2026,(6):819.[doi:DOI:10.3969/j.issn.1000-7369.2026.06.018]
ZHONG Yu,BO Yali,WANG Yishu,et al.LI Kunyin’s experience in treating premature ovarian failure based on the theories of “replenishment of essence with flavors” and the “tonification and drainage according to the desires and aversions of the five zang organs”[J].,2026,(5):819.[doi:DOI:10.3969/j.issn.1000-7369.2026.06.018]